Prospective observational study of antiphospholipid antibodies in acute lung injury and acute respiratory distress syndrome: Comparison with catastrophic antiphospholipid syndrome

Lupus

Volumn 12, Issue 6, 2003, Pages 462-467

  Wiedermann, Franz J ^a   Lederer, W ^a   Mayr, A J ^a   Sepp, N ^a   Herold, M ^b   Schobersberger, W ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Acute lung injury; Acute respiratory distress syndrome; Antiphospholipid antibodies; Bronchoalveolar lavage fluid; Catastrophic antiphospholipid syndrome

Indexed keywords

AUTOANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; PHOSPHATIDIC ACID ANTIBODY; PHOSPHATIDYLSERINE ANTIBODY; PHOSPHOLIPID ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNITY; BRAIN INFARCTION; CAPILLARY PERMEABILITY; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KIDNEY INFARCTION; LUNG ALVEOLUS; LUNG EMBOLISM; LUNG INJURY; LUNG LAVAGE; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY DISTRESS SYNDROME; SEPSIS; SPLEEN INFARCTION;

ADULT; AGED; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; BRONCHOALVEOLAR LAVAGE FLUID; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULINS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDIES; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 0037931550     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203303lu413oa     Document Type: Article

References (23)

1. Welty-Wolf KE, Carraway MS, Ortel TL, Piantodosi CA. Coagulation and inflammation in acute lung injury. Thromb Haemost 2002; 88: 17-25.
2. Asherson RA. The catastrophic antiphospholipid syndrome. J Rheumatol 1992; 19: 508-512.
3. Asherson RA, Cervera R, Piette JC et al. Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) 2001; 80: 355-377.
4. Asherson RA, Cervera R, Piette JC et al. Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore) 1998; 77: 195-207.
5. Asherson RA, Cervera R. Review: antiphospholipid antibodies and the lung. J Rheumatol 1995; 22: 62-66.
6. Wyncoll DLA, Evans TW. Acute respiratory distress syndrome. Lancet 1999; 354: 497-501.
7. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000; 342: 1334-1349.
8. Maneta-Peyret L, Kitsiouli E, Lekka M, Nakos G, Cassagne C. Autoantibodies to lipids in bronchoalveolar lavage fluid of patients with acute respiratory distress syndrome. Crit Care Med 2001; 29: 1950-1954.
9. Wiedermann FJ, Mayr A, Schobersberger W et al. Acute respiratory failure associated with catastrophic antiphospholipid syndrome. J Intern Med 2000; 247: 723-730.
10. Bernard GR, Artigas A, Brigham KL et al. The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818-824.
11. Rennard SI, Basset G, Lecossier D et al. Estimation of volume of epithelial lining fluid recovered by lavage using urea as a marker of dilution. J Appl Physiol 1986; 60: 532-538.
12. Levine JS, Ware Brach D, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002; 346: 752-763.
13. Shi W, Krilis SA, Chong BH, Gordon S, Chesterman CN. Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population. Aust NZ J Med 1990; 20: 231-236.
14. 2glycoprotein I in patients with antiphospholipid syndrome. J Clin Lab Anal 1998; 12: 293-297.
15. Wenzel C, Stoiser B, Locker GJ et al. Frequent development of lupus anticoagulants in critically ill patients treated under intensive care conditions. Crit Care Med 2002; 30: 763-770.
16. Dalekos GN, Zachou K, Liaskos C. The antiphospholipid syndrome and infection. Curr Rheumatol Rep 2001; 3: 277-285.
17. Rojas-Rodriguez J, Garcia-Carrasco M, Ramos-Casals M et al. Catastrophic antiphospholipid syndrome: clinical description and triggering factors in 8 patients. J Rheumatol 2000; 27: 238-240.
18. 2-glycoprotein I and atherosclerosis. Curr Opin Lipidol 2001; 12: 543-546.
19. Glueck CJ, Lang JE, Tracy T, Sieve-Smith L, Wang P. Evidence that anticardiolipin antibodies are independent risk factors for atherosclerotic vascular disease. Am J Cardiol 1999; 83: 1490-1494.
20. Asherson RA. Antiphospholipid antibodies, malignancies and paraproteinemias. J Autoimmunity 2000; 15: 117-122.
21. Holter JF, Weiland JE, Pacht ER, Gadek JE, Davis WB. Protein permeability in the adult respiratory distress syndrome: loss of size selectivity of the alveolar epithelium. J Clin Invest 1986; 78: 1513-1522.
22. Kitz R, Ahrens P, Zielen S. Immunoglobulin levels in bronchoalveolar lavage fluid of children with chronic chest disease. Pediatr Pulmonol 2000; 29: 443-451.
23. Fahy RJ, Diaz PT, Hart J, Wewers MD. BAL and serum IgG levels in healthy asymptomatic HIV-infected patients. Chest 2001; 119: 196-203.